BioSpace News Archive

EyePoint Pharmaceuticals, Inc. announced positive topline 36-month follow-up data from the second Phase 3 trial of YUTIQ® 0.18 mg three-year micro-insert for the treatment of chronic non-infectious uveitis affecting the posterior segment of the eye.

Innovation Pharmaceuticals (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, is pleased to provide scientific rationale and clinical development perspectives for Brilacidin, the Company’s defensin mimetic drug candidate, as a potential novel coronavirus (COVID-19) treatment.

Take a Lyft to your eye appointment! During ‘Save Your Vision’ month, the AOA’s new campaign encourages Americans to make eye health and vision care a priority in 2020 and beyond

Altavant Sciences, a clinical-stage biopharmaceutical company focused on patient-centric drug development in rare respiratory diseases, announced that it has appointed Howard M. Lazarus, M.D., to the newly created position of Chief Medical Officer.

EmblemHealth, one of the nation’s largest non-profit health insurers, announced it was named the winner of two Stevie® Awards in the 14th annual Awards for Sales & Customer Service.

The Leukemia & Lymphoma Society (LLS) announced today three new appointments to its leadership team, Troy Dunmire, EVP, chief operating officer, Lynn Godfrey, EVP, chief marketing officer and Dale Nissenbaum, EVP, general counsel.

Humacyte, an innovator in biotechnology and regenerative medicine, announced today that company founder, Laura Niklason, M.D., Ph.D., a world leader in tissue engineering and cellular therapies, has been elected to the prestigious National Academy of Engineering (NAE).

Prodigo Solutions and their community of leading healthcare providers are proud to announce that we have a new way of communicating your product content with Prodigo’s Global Catalog.

Athenex, Inc. (NASDAQ: ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies for the treatment of cancer and related conditions, provided an update today that its partner, Almirall, announced that the European Medicines Agency (EMA) has accepted the filing of the Marketing Authorization Application (MAA) for tirbanibulin ointment for the treatment of actinic keratosis.

Saki Corporation, an innovator in the field of automated optical and X-ray inspection equipment, announces the opening of Saki’s new manufacturing plant in Yamato Koriyama City, Nara Prefecture for the manufacture of 3D automated X-ray inspection equipment to meet the increased demand for X-ray inspection in the Smart Factory.